MedPage Today

Antibody-Drug Conjugates Expand as First-Line Option in Metastatic Triple-Negative Breast Cancer

(MedPage Today) -- Antibody-drug conjugates (ADCs) are becoming an increasingly relevant first-line treatment option for metastatic triple-negative breast cancer (TNBC). "ADCs are a fairly old class of drug that has really transformed the treatment...